Report cover image

Diabetic Retinopathy Market

Publisher Future Market Insights
Published Jun 06, 2022
Length 324 Pages
SKU # FMARI17600333

Description

Diabetic Retinopathy Market

Diabetic Retinopathy Market: Global Industry Analysis 2015-2021 and Opportunity Assessment 2022-2032

A recent market study published by FMI on Diabetic Retinopathy offers a global industry analysis for 2015-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The global Diabetic Retinopathy Market is segmented in detail tcover every aspect of the market and present complete market intelligence treaders.

By Type

Proliferative
  • Non-proliferative
By Management

Anti VEGF
  • Intraocular Steroid Injection
  • Laser Surgery
  • Vitrectomy
By Region

North America
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • Latin America
Report Chapters

Executive Summary

The executive summary of the Diabetic Retinopathy Market includes the global market outlook, demand side trends, supply side trends and alsinclude FMI analysis and recommendations of Diabetic Retinopathy.

Chapter 01 – Market Overview

Readers can find the detailed segmentation and definition of the Diabetic Retinopathy Market in this chapter, which will help tunderstand basic information about Diabetic Retinopathy. This section alshighlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Diabetic Retinopathy Market report.

Chapter 02 – Market Background

This chapter includes detailed analysis of the product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It alsincludes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter alscovers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) tbetter understand the market.

Chapter 03 – Global Diabetic Retinopathy Market Demand Analysis 2015-2021 and Forecast, 2022-2032

The chapter include historical market value (US$ XX Billion) analysis (2015-2021) and current and future market value (US$ 8.4Bn) and volume (5.8%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 – Global Diabetic Retinopathy Market - Pricing Analysis

Based on By Type, the pricing analysis chapter include regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 – Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Type

Based on By Type, Diabetic Retinopathy Market is segmented intProliferative and Non-proliferative. This section alsoffers market attractiveness analysis based on By Type. Value forecast and Y-o-Y growth comparison will alsbe provided for above mentioned By Type.

Chapter 06 – Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Management

Based on By Management, Diabetic Retinopathy Market is segmented intAnti VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy. This section alsoffers market attractiveness analysis based on By Management. Readers can alsfind value forecast and y-o-y growth comparison for all above mentioned By Management.

Chapter 07 – Global Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032, By Region

Based on By Region, Diabetic Retinopathy Market is segmented intNorth America, Asia-Pacific, Europe, Middle East & Africa, Latin America. This section alsoffers market attractiveness analysis based on By Region. Readers can alsfind value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 08 – North America Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the Diabetic Retinopathy in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can alsfind regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 09 – Latin America Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexicand Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the Latin America region.

Chapter 10 – Asia-Pacific Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the Asia-Pacific region, along with a country-wise assessment that includes the China, Japan, South Korea and Rest of Asia Pacific. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the regional market.

Chapter 11 – Europe Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the regional market.

Chapter 12 - Middle East and Africa Diabetic Retinopathy Market Analysis 2015-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Diabetic Retinopathy in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Diabetic Retinopathy Market in the regional market.

Chapter 13 - Key Countries Diabetic Retinopathy Market Analysis 2015–2021 and Forecast 2022–2032

This chapter offers insights inthow the Diabetic Retinopathy Market is expected tgrow in major countries globally.

Chapter 14 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 15 - Competition Deep Dive (Tentative List)

This chapter includes company overview, product portfoliof companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Bayer Healthcare, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc, Oxurion, and others

Chapter 16 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base tthe information and statistics included in the Diabetic Retinopathy Market report.

Chapter 17 – Research Methodology

This chapter helps readers understand the research methodology followed tobtain various conclusions, as well as important qualitative and quantitative information, on Diabetic Retinopathy Market.

Table of Contents

324 Pages
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Protective Coatings Market (US$ Mn)
4.2. Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Protective Coatings Market Growth
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032
8.3.1. Proliferative
8.3.2. Non-proliferative
8.4. Market Attractiveness Analysis By Type
9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Management
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Management, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Management, 2022-2032
9.3.1. Anti VEGF
9.3.2. Intraocular steroid injection
9.3.3. Laser surgery
9.3.4. Vitrectomy
9.4. Market Attractiveness Analysis By Management
10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2015-2021 and Forecast 2022-2032
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Type
11.4.3. By Management
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Type
11.5.3. By Management
12. Latin America Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Type
12.4.3. By Management
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Type
12.5.3. By Management
13. Europe Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. U.K.
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Type
13.4.3. By Management
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Type
13.5.3. By Management
14. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Type
14.4.3. By Management
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Type
14.5.3. By Management
15. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Type
15.4.3. By Management
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Type
15.5.3. By Management
16. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.2.2.1. By Type
16.2.2.2. By Management
16.3. Canada Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.3.2.1. By Type
16.3.2.2. By Management
16.4. Mexico Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.4.2.1. By Type
16.4.2.2. By Management
16.5. Brazil Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.5.2.1. By Type
16.5.2.2. By Management
16.6. Germany Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.6.2.1. By Type
16.6.2.2. By Management
16.7. France Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.7.2.1. By Type
16.7.2.2. By Management
16.8. Italy Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.8.2.1. By Type
16.8.2.2. By Management
16.9. BENELUX Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.9.2.1. By Type
16.9.2.2. By Management
16.10. UK Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.10.2.1. By Type
16.10.2.2. By Management
16.11. Nordic Countries Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.11.2.1. By Type
16.11.2.2. By Management
16.12. China Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.12.2.1. By Type
16.12.2.2. By Management
16.13. Japan Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.13.2.1. By Type
16.13.2.2. By Management
16.14. South Korea Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.14.2.1. By Type
16.14.2.2. By Management
16.15. GCC Countries Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.15.2.1. By Type
16.15.2.2. By Management
16.16. South Africa Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.16.2.1. By Type
16.16.2.2. By Management
16.17. Turkey Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.17.2.1. By Type
16.17.2.2. By Management
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Bayer Healthcare
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. Novartis AG
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. Regeneron Pharmaceuticals Inc.
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Allergan plc
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. Oxurion
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. Sirnaomics, Inc.
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
18.3.7. Genentech
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Strategy Overview
18.3.8. Glycadia Pharmaceuticals
18.3.8.1. Overview
18.3.8.2. Product Portfolio
18.3.8.3. Sales Footprint
18.3.8.4. Strategy Overview
18.3.9. Alimera Sciences
18.3.9.1. Overview
18.3.9.2. Product Portfolio
18.3.9.3. Sales Footprint
18.3.9.4. Strategy Overview
18.3.10. Ampio Pharmaceuticals
18.3.10.1. Overview
18.3.10.2. Product Portfolio
18.3.10.3. Sales Footprint
18.3.10.4. Strategy Overview
18.3.11. BCN Peptides
18.3.11.1. Overview
18.3.11.2. Product Portfolio
18.3.11.3. Sales Footprint
18.3.11.4. Strategy Overview
18.3.12. Kowa Group
18.3.12.1. Overview
18.3.12.2. Product Portfolio
18.3.12.3. Sales Footprint
18.3.12.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us